Abstract

Re-evaluating the role of isoniazid in treatment of pulmonary tuberculosis

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations
Jacopo Marazzato ... Roberto De Ponti
European Journal of Internal Medicine | VOL. 95
Jacopo Marazzato, et. al.Jacopo Marazzato ... Roberto De Ponti
14 Oct 2021
Aromatase inhibitors prevent the estrogen rise associated with the flare effect of gonadotropins in patients treated with GnRH agonists
Robert F Casper ... Noha A Mousa
Fertility and Sterility | VOL. 91
Robert F Casper, et. al.Robert F Casper ... Noha A Mousa
29 Oct 2008
A tricompartmental model of lung oxygenation disruption to explain pulmonary and systemic pathology in severe COVID-19
Dennis Mcgonagle ... James F M Meaney
The Lancet Respiratory Medicine | VOL. 9
Dennis Mcgonagle, et. al.Dennis Mcgonagle ... James F M Meaney
14 May 2021
An In Vivo Platform for Rapid High-Throughput Antitubercular Drug Discovery
Lalita Ramakrishnan ... Christine L Cosma
Cell Reports | VOL. 2
Lalita Ramakrishnan, et. al.Lalita Ramakrishnan ... Christine L Cosma
01 Jul 2012
View more papers

More From: The Lancet Microbe

Paper Title
Journal
Date
Author
Additional breastfeeding data essential to better understand kinetics of A (H1N1) pdm09 strain-specific antibodies induced by placental transfer and natural infection in children from birth to 3 years of age
Yulei Li
The Lancet Microbe | VOL. -
Yulei LiYulei Li
16 May 2024
Additional thoughts on group A streptococci
Dingle Yu ... Yonghong Yang
The Lancet Microbe | VOL. -
Dingle Yu, et. al.Dingle Yu ... Yonghong Yang
06 May 2024
SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial
Brittany L Ober Shepherd ... Michal Gazi
The Lancet Microbe | VOL. -
Brittany L Ober Shepherd, et. al.Brittany L Ober Shepherd ... Michal Gazi
01 May 2024
Borealpox (Alaskapox) virus: will there be more emerging zoonotic orthopoxviruses?
Nicola Douglass
The Lancet Microbe | VOL. -
Nicola DouglassNicola Douglass
01 May 2024
View more papers